Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- KATE2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced…
- KEEPsAKE 1Independent statistical analysis of A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease…
- KETAMINEIndependent statistical analysis of Administration of Ketamine to Prevent the Post-operative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00210210).
- Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study: Complete Statistical AnalysisIndependent statistical analysis of Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): Complete Statistical AnalysisIndependent statistical analysis of Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- KEYNOTE-010Independent statistical analysis of KEYNOTE-010, including its randomized phase 2/3 design, overall survival, progression-free survival, response, safety, statistical methods, and interpretation.
- KEYNOTE-040Independent statistical analysis of KEYNOTE-040, a randomized phase 3 trial of pembrolizumab versus standard treatment for recurrent or metastatic head and neck squamous cell cancer, including overall survival, progression-free survival, response, statistical…
- KEYNOTE-189Independent statistical analysis of KEYNOTE-189 (NCT02578680), a randomized phase 3 trial evaluating pembrolizumab with pemetrexed-platinum chemotherapy in first-line metastatic nonsquamous non-small cell lung cancer.
- KEYNOTE-240Independent statistical analysis of KEYNOTE-240, a randomized phase 3 trial of pembrolizumab plus best supportive care versus placebo plus best supportive care in previously systemically treated advanced hepatocellular carcinoma.
- KEYNOTE-394Independent statistical analysis of KEYNOTE-394, a randomized phase 3 trial of pembrolizumab or placebo with best supportive care in Asian participants with previously treated advanced hepatocellular carcinoma.
- KEYNOTE-671Independent statistical analysis of KEYNOTE-671, a randomized phase 3 trial of pembrolizumab with platinum-doublet chemotherapy as neoadjuvant/adjuvant therapy for resectable stage II, IIIA, and resectable IIIB non-small cell lung cancer.
- KEYNOTE-A18Independent statistical analysis of KEYNOTE-A18 (NCT04221945), a randomized phase 3 trial of chemoradiotherapy with or without pembrolizumab in locally advanced cervical cancer, including primary time-to-event results, secondary endpoints, cLDA, stratified analysis, and…
- KHLADIndependent statistical analysis of Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00953576).
- KIDPROAMIndependent statistical analysis of Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- KINGIndependent statistical analysis of Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- KIRMONOIndependent statistical analysis of Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- KIS-IVIndependent statistical analysis of Advancing Tobacco Use Treatment for African American Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02360631).
- KISSIndependent statistical analysis of Aripiprazole, Abilify Maintena Collaborative Clinical Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02472652).
- KIU!Independent statistical analysis of Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men: primary endpoint results, effect estimate with confidence interval,…
- KOMETIndependent statistical analysis of Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- KontRASt-06Independent statistical analysis of Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1…
- KPL-301 for Subjects With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of KPL-301 for Subjects With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03827018).
- Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114971).
- Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LADIIIndependent statistical analysis of Labor and Delivery Implant Insertion: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02866643).
- LAL1610Independent statistical analysis of Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lamotrigine Extended-Release In Elderly Patients With Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Extended-Release In Elderly Patients With Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00516139).
- Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients: Complete Statistical AnalysisIndependent statistical analysis of Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383708).
- Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases: Complete Statistical AnalysisIndependent statistical analysis of Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01944930).
- Laparoscopic Versus Open Appendectomy? Let the Patient Decide: Complete Statistical AnalysisIndependent statistical analysis of Laparoscopic Versus Open Appendectomy? Let the Patient Decide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01738750).
- Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen: primary endpoint results, effect estimate with confidence interval,…
- Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ): Complete Statistical AnalysisIndependent statistical analysis of Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LaPPSIndependent statistical analysis of LaPPS: Labor Podcast for Patient Satisfaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04933708).
- Laser Treatment for Vulvar Lichen Sclerosus: Complete Statistical AnalysisIndependent statistical analysis of Laser Treatment for Vulvar Lichen Sclerosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04134494).
- LaserFissureIndependent statistical analysis of Fissure Caries Inhibition Study With Solea CO2-9.3μm Short-pulsed Laser: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02357979).
- LASORIndependent statistical analysis of Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Late-Onset Treatment Study Extension Protocol: Complete Statistical AnalysisIndependent statistical analysis of Late-Onset Treatment Study Extension Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455195).
- Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A: Complete Statistical AnalysisIndependent statistical analysis of Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.: Complete Statistical AnalysisIndependent statistical analysis of LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Latino-SMARTIndependent statistical analysis of An Adaptive Intervention for Depression Among Latinos Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03668379).
- LCCC1407Independent statistical analysis of Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276560).
- LCIOADMT2Independent statistical analysis of Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib: Complete Statistical AnalysisIndependent statistical analysis of LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LDP0114Independent statistical analysis of Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LEADER7Independent statistical analysis of Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LEAP-001Independent statistical analysis of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LEAP2Independent statistical analysis of Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…